文献速递外周血管腹部胸部MR

对比剂剂量降低对胸腹部动态三维磁共振血管成像血管强化及图像质量的影响:猪体系统个体内分析

Effect of Contrast Agent Dose Reduction on Vascular Enhancement and Image Quality in Thoracoabdominal Dynamic 3-Dimensional Magnetic Resonance Angiography: A Systematic Intraindividual Analysis in Pigs.
PubMed 文献 · Invest Radiol · 2022-04-30

在5只哥廷根小型猪中,以标准剂量(0.1 mmol/kg)及降低剂量(0.08、0.06、0.04、0.02 mmol/kg)钆布醇行1.5T胸腹部动态三维MRA,定量分析显示腹主动脉、肾动脉、下腔静脉、门静脉信号随剂量线性下降(r²=0.96–0.99),动脉段图像质量在低于标准剂量40%时显著降低,静脉段在低于60%时显著降低。作者认为动静脉系统动态3D-MRA宜用标准剂量60%至全剂量,仅动脉成像时40%剂量似乎可行。

要点

  • 静脉系统对剂量降低最敏感,低于标准剂量60%时图像质量显著下降。
  • 动脉段在低于标准剂量40%时图像质量显著降低。
  • 肺主动脉干峰值信号几乎不依赖剂量,但腹主动脉等部位信号随剂量线性下降。

核心结论

  • 在1.5T动态三维MRA中,剂量降低导致信号丢失,以静脉系统最明显,图像质量下降程度取决于剂量和所关注的血管。

研究设计与样本

  • 动物实验,5只麻醉哥廷根小型猪,个体间及个体内比较,随机顺序注射钆布醇标准剂量(0.1 mmol/kg,即0.1 mL/kg)及降低剂量(0.08、0.06、0.04、0.02 mmol/kg),1.5T时间分辨血管成像(TWIST),注射速度2 mL/s后跟20 mL生理盐水。

关键影像表现/征象

  • 随着钆布醇剂量和体积降低,所有血管的达峰时间间期和团注持续时间缩短。
  • 肺主动脉干水平峰值信号几乎不依赖所给剂量,而腹主动脉(r²=0.96)、肾动脉(r²=0.99)、下腔静脉(r²=0.99)和门静脉(r²=0.97)呈线性信号下降。

诊断标准与关键数值

  • 定量分析测量5个区域信号强度,覆盖肺、动脉和静脉系统不同循环阶段。
  • 定性分析由3名独立放射科医师评估25个动静脉血管段在不同钆布醇通过阶段的可见性。
  • 动脉段累积分析显示剂量低于标准剂量40%时图像质量显著降低。
  • 静脉段剂量低于标准剂量60%时图像质量显著降低。

临床应用与阅片要点

  • 作者认为,动静脉系统动态3D-MRA宜使用至少标准剂量60%至全剂量。
  • 作者认为,仅行动脉系统成像时标准剂量40%似乎可行。
  • 阅片时应注意静脉系统信号丢失较动脉更明显,剂量降低需根据具体诊断需求谨慎进行。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: High spatial and temporal resolution contrast-enhanced magnetic resonance angiography (MRA) with gadolinium-based contrast agents (GBCAs) at standard dose offers both detailed anatomic information on both arterial and venous vessels and hemodynamic characteristics. Several preclinical and clinical dynamic 3-dimensional (3D) MRA studies that focused on arterial vessels only proposed that high image quality may also be achieved with significantly reduced GBCA doses, calling into question the need to use standard doses. A systematic analysis of GBCA doses and resulting image quality for both arteries and veins has not yet been performed. The purpose of this study was therefore to systematically analyze dose-dependent vascular enhancements in dynamic 3D-MRA of the thoracoabdominal vasculature at 1.5 T in an animal model to determine the optimal contrast agent protocol for optimized vascular assessment.

MATERIALS AND METHODS: The vascular enhancement in thoracoabdominal dynamic 3D-MRA (time-resolved angiography with interleaved stochastic trajectories, TWIST at 1.5 T) was interindividually and intraindividually compared in 5 anesthetized Göttingen minipigs using gadobutrol at the standard dose (0.1 mmol/kg body weight, ie, 0.1 mL/kg) and at reduced doses (0.08, 0.06, 0.04, 0.02 mmol/kg) in a randomized order. All injections were performed at 2 mL/s followed by 20 mL saline. Images were quantitatively analyzed, measuring signal intensities in 5 regions that covered the passage of the GBCA through the body at different representative stages of circulation (pulmonary, arterial, and venous system). The evaluation of GBCA dose-dependent signal intensity changes in the different vascular regions was performed by linear regression analysis.The qualitative image analysis of dynamic 3D-MRA by 3 independent radiologists included the visibility of 25 arterial and venous vessel segments at different stages of GBCA passage. Possible quality losses were statistically tested by comparing image quality ratings at the reduced dose with that of the standard dose using Friedman test followed by Dunn post hoc test for multiple comparison. Significance was stated at P < 0.05.

RESULTS: Quantitative analysis revealed shorter time-to-peak intervals and bolus durations in line with decreasing GBCA dose and volume in all vessels. Although the peak signal was almost independent of the administered GBCA dose at the level of the pulmonary trunk, a linear signal decrease in the abdominal aorta ( r2 = 0.96), the renal arteries ( r2 = 0.99), the inferior vena cava ( r2 = 0.99), and the portal vein ( r2 = 0.97) was observed. Cumulative analysis of arterial segments revealed significantly lower image quality at doses below 40% of the standard dose, whereas in venous segments, significantly lower image quality was observed at doses below 60% of the standard dose.

CONCLUSIONS: In dynamic 3D-MRA at 1.5 T, dose reduction leads to a signal loss that is most pronounced in the venous system and results in significantly lower image quality according to the dose and vessels of interest. Careful dose reduction is thus required according to the specific diagnostic needs. For dynamic 3D-MRA of the arterial and venous system, GBCA doses of at least 60% of the standard dose up to the full dose are preferable, whereas 40% of the standard dose seems feasible if only the arterial system is to be imaged.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Endler, Jost, Pietsch, et al. Effect of Contrast Agent Dose Reduction on Vascular Enhancement and Image Quality in Thoracoabdominal Dynamic 3-Dimensional Magnetic Resonance Angiography: A Systematic Intraindividual Analysis in Pigs. Invest Radiol. 2022. PMID: 35510876. doi:10.1097/RLI.0000000000000882

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。